Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
10 hedge funds and large institutions have $1.24M invested in Yield10 Bioscience, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
122% more capital invested
Capital invested by funds: $557K → $1.24M (+$682K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more funds holding
Funds holding: 10 → 10 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$284K |
| 2 |
BlackRock
New York
|
+$60.2K |
| 3 |
Renaissance Technologies
New York
|
+$14.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$110K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$21K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Birchview Capital
Burlington,
Vermont
| $807K | – | – | – |
|
|
CC
2
Cannell & Co
New York
| $284K | +$284K | +80 | New |
|
|
3
BlackRock
New York
| $59K | +$60.2K | +17 | New |
|
4
Goldman Sachs
New York
| $21K | – | – | – |
|
|
FA
5
FCG Advisors
Chatham,
New Jersey
| $16K | – | – | – |
|
|
6
Renaissance Technologies
New York
| $14K | +$14.2K | +4 | New |
|
7
Geode Capital Management
Boston,
Massachusetts
| $13K | – | – | – |
|
8
Citadel Advisors
Miami,
Florida
| $11K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $6K | +$3.54K | +1 | +100% |
|
10
Vanguard Group
Malvern,
Pennsylvania
| $4K | – | – | – |
|
11
Group One Trading
Chicago,
Illinois
| $1K | – | – | – |
|
12
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | – | – | – |
|
13
Morgan Stanley
New York
| $1K | – | – | – |
|
|
PSC
14
Prentiss Smith & Co
Brattleboro,
Vermont
| $1K | – | – | – |
|
|
WEC
15
Winslow Evans & Crocker
Boston,
Massachusetts
| $14 | – | – | – |
|
|
GC
16
GMT Capital
Atlanta,
Georgia
| – | -$110K | -33 | Closed |
|
|
VKH
17
Virtu KCG Holdings
New York
| – | -$21K | -6 | Closed |
|
YTEN Hedge Fund Activity: Q1 2017 in Review
10 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2017, worth a combined $1.24M — up 122% from $557K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new YTEN positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Cannell & Co, opening a new position worth an estimated $284K. The largest seller was GMT Capital, exiting entirely with an estimated $110K sold.
- 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $1.24M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2017, up 122% quarter-over-quarter.
- 3 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2017 and 2 closed out, a net change of +1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2017 was Cannell & Co, an estimated $284K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2017 was GMT Capital, an estimated $110K sold.
Based on aggregated 13F filings for Q1 2017.